Godavari Biorefineries Limited (IN:GODAVARIB)
:GODAVARIB
Want to see IN:GODAVARIB full AI Analyst Report?
Top Page
Godavari Biorefineries Limited
(GODAVARIB)
Select Model
Select Model
Rating:48Neutral
Price Target:
₹290.00
▼(-9.70% Downside)
Action:N/A
Date:05/26/26
The score is primarily constrained by weak financial quality (very thin net margins and negative free cash flow) and a demanding valuation (P/E ~43). Technical signals are also modestly negative with the stock below key short-term moving averages, despite mixed momentum indicators.
Positive Factors
Diversified biorefinery model
Godavari's integrated biorefinery converts sugarcane into sugar, ethanol, chemical intermediates and power co-products. This product and end-market diversification reduces reliance on volatile sugar prices, supports margin mix improvement, and creates durable optionality across industrial and fuel channels.
Negative Factors
Very thin net margins
Net margins close to zero leave limited buffer versus input cost swings or pricing pressure. Fragile profitability means small adverse moves in cane prices, energy costs or product spreads can push the company back to losses, undermining sustainable earnings power over months ahead.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified biorefinery model
Godavari's integrated biorefinery converts sugarcane into sugar, ethanol, chemical intermediates and power co-products. This product and end-market diversification reduces reliance on volatile sugar prices, supports margin mix improvement, and creates durable optionality across industrial and fuel channels.
Read all positive factors
Godavari Biorefineries Limited (GODAVARIB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹14.58B
Dividend YieldN/A
Average Volume (3M)10.95K
Price to Earnings (P/E)407.0
Beta (1Y)1.21
Revenue Growth6.29%
EPS GrowthN/A
CountryIN
Employees1,692
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)6.70
Shares Outstanding51,175,976
10 Day Avg. Volume12,666
30 Day Avg. Volume10,946
Financial Highlights & Ratios
PEG Ratio-3.80
Price to Book (P/B)1.93
Price to Sales (P/S)0.77
P/FCF Ratio-34.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Godavari Biorefineries Limited Business Overview & Revenue Model
Company Description
Godavari Biorefineries Limited manufactures and sells sugar in India. It provides distillery, including ethanol, bio-chemicals, and other bio products; and classic and brown sugar, plantation white sugar, and refined sugar. The company also offers...
How the Company Makes Money
Godavari Biorefineries makes money by converting sugarcane into multiple saleable product streams and selling them into both consumer and industrial markets. (1) Sugar segment: Revenue is generated from the sale of sugar produced from sugarcane; r...
Godavari Biorefineries Limited Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
62
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2025 | Mar 2025 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 10.10B | 19.88B | 18.70B |
| Gross Profit | 1.39B | 3.72B | 3.14B |
| EBITDA | 825.18M | 1.27B | 1.12B |
| Net Income | 303.35M | 35.28M | -234.15M |
Balance Sheet | |||
| Total Assets | 14.63B | 20.52B | 19.55B |
| Cash, Cash Equivalents and Short-Term Investments | 531.59M | 321.53M | 122.51M |
| Total Debt | 4.93B | 5.31B | 4.90B |
| Total Liabilities | 7.38B | 12.64B | 11.73B |
| Stockholders Equity | 7.25B | 7.88B | 7.82B |
Cash Flow | |||
| Free Cash Flow | -498.40M | -446.91M | -654.94M |
| Operating Cash Flow | 672.11M | 1.24B | 61.52M |
| Investing Cash Flow | -1.12B | -1.66B | -687.56M |
| Financing Cash Flow | 485.61M | 444.35M | 637.43M |
Godavari Biorefineries Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹10.37B | 7.94 | ― | 0.82% | 13.96% | 343.65% | |
65 Neutral | ₹10.69B | 30.68 | ― | 0.26% | -13.58% | -10.91% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹6.58B | 15.24 | ― | 1.23% | -5.04% | -26.70% | |
60 Neutral | ₹8.43B | 25.06 | ― | ― | 2.78% | ― | |
52 Neutral | ₹7.73B | 144.06 | ― | 1.07% | -14.55% | -74.70% | |
48 Neutral | ₹14.58B | 407.04 | ― | ― | 6.29% | ― |
* Basic Materials Sector Average
IN:GODAVARIB
Godavari Biorefineries Limited
281.20
-3.60
-1.26%
IN:AMNPLST
Amines & Plasticizers Ltd.
190.55
-33.15
-14.82%
IN:FAIRCHEMOR
Fairchem Organics Ltd
618.80
-222.20
-26.42%
IN:JAYAGROGN
Jayant Agro-Organics Limited
222.20
-38.05
-14.62%
IN:MANALIPETC
Manali Petrochemicals Limited
60.24
4.05
7.21%
IN:VALIANTORG
Valiant Organics Limited
296.80
-161.90
-35.30%
Godavari Biorefineries Limited Corporate Events
Godavari Biorefineries files Q4 and FY26 investor presentation with exchanges
May 25, 2026
Godavari Biorefineries Limited has released its investor presentation for the fourth quarter and full year ended March 31, 2026, in line with its disclosure obligations to the stock exchanges. The presentation, shared with investors and regulators...
Godavari Biorefineries Posts Revenue Growth but Softer Margins in Q4 and FY26
May 22, 2026
Godavari Biorefineries Limited reported consolidated total income of Rs 570 crore for the March quarter of FY26, down 3.2% year-on-year but up 23.4% sequentially, reflecting a rebound despite industry headwinds. The company’s EBITDA for the ...
Godavari Biorefineries Hits Record Sugarcane Crushing at Sameerwadi Unit
Apr 5, 2026
Godavari Biorefineries Limited has reported a record sugarcane crushing volume of 2.5 million tonnes during the 2025-26 crushing season at its Sameerwadi unit, marking the highest output in a single crushing session in the company’s history....
CARE reaffirms Godavari Biorefineries’ BBB+ rating amid sector headwinds
Mar 17, 2026
Godavari Biorefineries Limited said CARE Ratings has reaffirmed its credit profile, maintaining a CARE BBB+ Stable rating on its long-term bank facilities and fixed deposits, and a CARE A2 rating on its short-term bank facilities. The reaffirmatio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.